Back to Journals » Lung Cancer: Targets and Therapy » Volume 1 » Default

Lung Cancer: Targets and Therapy


Archive: Volume 1, 2010

Dyspnea in lung cancer patients: a systematic review

Ganesan Kathiresan, Reynold F Clement, Meera T Sankaranarayanan

Lung Cancer: Targets and Therapy 2010, 1:141-150

Published Date: 23 November 2010

Azacitidine and decitabine have different mechanisms of action in non-small cell lung cancer cell lines

Aaron N Nguyen, Paul W Hollenbach, Normand Richard, et al

Lung Cancer: Targets and Therapy 2010, 1:119-140

Published Date: 10 September 2010

Genome-wide gene expression analysis of chemoresistant pulmonary carcinoid cells

Ulrike Olszewski, Robert Zeillinger, Klaus Geissler, et al

Lung Cancer: Targets and Therapy 2010, 1:107-117

Published Date: 6 September 2010

The role of maintenance pemetrexed in the treatment of non-small-cell lung cancer

Saeed Rafii, Michael H Cullen

Lung Cancer: Targets and Therapy 2010, 1:101-106

Published Date: 30 July 2010

Circulating tumor cells (CTCs) in lung cancer: current status and future perspectives

Fumihiro Tanaka, Kazue Yoneda, Seiki Hasegawa

Lung Cancer: Targets and Therapy 2010, 1:77-84

Published Date: 7 July 2010

Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysis

Matthew A Gubens, Heather A Wakelee

Lung Cancer: Targets and Therapy 2010, 1:63-76

Published Date: 16 June 2010

Drug resistance in lung cancer

Manish Shanker, David Willcutts, Jack A Roth, et al

Lung Cancer: Targets and Therapy 2010, 1:23-36

Published Date: 13 May 2010

Refining the treatment of advanced nonsmall cell lung cancer

Shin Ogita, Antoinette J Wozniak

Lung Cancer: Targets and Therapy 2010, 1:9-22

Published Date: 4 May 2010